Vascular Access Complication Clinical Trial
Official title:
Vascular Access in Hematological Patients - PICC Versus CVC in a Phase IV Randomized Controlled Trial
The use of peripherally inserted central catheters (PICCs) represents a major advance for hematological patients, enabling the effective delivery of chemotherapy and/or blood products particularly for prolonged infusions or in situation of difficult venous access. In modern medical practice their use has increased rapidly for several reasons, including ease of insertion, many uses (e.g., drug administration and venous access), perceived safety, and cost-effectiveness compared with centrally inserted central catheters (CICCs).
The use of peripherally inserted central catheters (PICCs) represents a major advance for hematological patients, enabling the effective delivery of chemotherapy and/or blood products particularly for prolonged infusions or in situation of difficult venous access. In modern medical practice their use has increased rapidly for several reasons, including ease of insertion, many uses (e.g., drug administration and venous access), perceived safety, and costeffectiveness compared with centrally inserted central catheters (CICCs). Despite these benefits, PICCs are associated with deep vein thrombosis of the arm and pulmonary embolism. These complications, which are often called venous thromboembolism, are important because they not only complicate and interrupt treatment, but also increase cost, morbidity and mortality. Despite this effect, the burden and risk of PICC-related venous thromboembolism is uncertain and clinicians have scarce evidence on which to base choice of vascular access. Evidence to choose one vascular access over the other is lacking in literature, in particular for patients affected by haematological malignancies, in which chemotherapy is more likely to cause myelosuppression, with a major risk of bloodstream infections. Furthermore, the precise incidence and the risk of PICC-related venous thromboembolism relative to that of other CICCs is unknown. An understanding of this risk in the context of growing PICC use is an important cost and patients safety questions. Up to now, no systematic review has been done to investigate these questions. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT04136561 -
Novel Strategy to Encourage Early Removal of Central Venous Catheters
|
N/A | |
Active, not recruiting |
NCT04054128 -
Bicarbonate vs Heparin Catheter Lock in Chronic Hemodialysis Patients
|
Phase 4 | |
Completed |
NCT02297308 -
A Retrospective Study Evaluating the Use of the SoloPath® Sheath in Reducing Vascular and Bleeding Complications
|
N/A | |
Completed |
NCT01446263 -
RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention (RADIAL-CABG) Trial
|
Phase 3 | |
Recruiting |
NCT05132712 -
Effects of Angiotensin Converting Enzyme Inhibitors on Patency of Arterio-Venous Fistulas: A Randomized Controlled Trial
|
Early Phase 1 | |
Completed |
NCT02513303 -
Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes
|
Phase 3 | |
Completed |
NCT02200458 -
Near-infrared Software Performance Study
|
N/A | |
Recruiting |
NCT06001827 -
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
|
N/A | |
Recruiting |
NCT04077762 -
Radial vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)
|
N/A | |
Completed |
NCT05982366 -
Feasibility and Safety of the Routine Distal Transradial Approach
|
N/A | |
Completed |
NCT05101720 -
Ultrasound Guided Axillary Access vs Standard Fluoroscopic Technique for Cardiac Lead Implantation: ZEROFLUOROAXI TRIAL
|
N/A | |
Terminated |
NCT03879824 -
Radial Versus Femoral Secondary Access During TAVI
|
N/A | |
Recruiting |
NCT05741866 -
Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs)
|
N/A | |
Completed |
NCT05093699 -
Dual-plane Ultrasound Imaging During Vascular Access Procedures
|
N/A | |
Recruiting |
NCT02449798 -
Prospective Feasibility Trial of AccuCath 2.25" BC Placed in Difficult Access Patients in the Emergency Department
|
N/A | |
Active, not recruiting |
NCT02808208 -
Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure
|
Phase 1/Phase 2 | |
Completed |
NCT04409418 -
Blood Sampling Functionality of Extended Dwell Catheters
|
N/A | |
Recruiting |
NCT04472221 -
Arterio-arterial Vascular Access as a Novel Technique for Treatment of Venous Hypertention With Arterio-venous Vascular Access
|
N/A | |
Completed |
NCT02558153 -
RCT of Paclitaxel DEB Compared to Standard PTA in Dialysis Fistula
|
N/A | |
Completed |
NCT01927185 -
Long-versus Short-Axis Ultrasound Guidance for Subclavian Vein Cannulation
|
N/A |